FDA.reportPublic FDA data

NDC 50090-6630-01 - Ezetimibe

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
50090-6630
Requested NDC
50090-6630-01
Package NDCs from labels
50090-6630-0, 50090-6630-1, 50090-6630-01
Manufacturer
A-S Medication Solutions
Effective date
2026-07-06
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Ezetimibe - A-S Medication SolutionsA-S Medication Solutions2026-07-06Human Prescription Drug Label

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50090-6630-0Ezetimibe30 in 1 BOTTLETABLET301
50090-6630-1Ezetimibe90 in 1 BOTTLETABLET901

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50090-6630EZETIMIBE TABLET [A-S MEDICATION SOLUTIONS]1Current NDC, 2 package rows20230901_090776cf-f211-49a3-a993-ff5d707311f2.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50090-6630-0EA - Each50090-663091a2d493-773b-43e1-83ca-8d74d00fd23212023-10-16
50090-6630-1EA - Each50090-6630b9daa56e-9c49-452d-943f-c941cd39e3a712023-10-16

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 3 · 59 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EzetimibeEZETIMIBEAscend Laboratories, LLC206d702c-b09a-4555-972b-6555d6d6d6e62025-06-13Warnings, Adverse reactionsExact identifier
rxcui: 349556
unii: EOR26LQQ24
EzetimibeEZETIMIBEBryant Ranch Prepack3a80b668-51cd-42be-8497-8712b05084222025-05-12Warnings, Adverse reactionsExact identifier
application number: ANDA209838
rxcui: 349556
unii: EOR26LQQ24
Ezetimibe and SimvastatinEZETIMIBE AND SIMVASTATINAscend Laboratories, LLCc90e8c96-e130-42d7-bf0d-5833652e40d52025-05-02Warnings, Adverse reactionsExact identifier
unii: EOR26LQQ24
EzetimibeEZETIMIBEAurobindo Pharma Limited726b1e63-437a-4b3b-b773-3ac47a5c0f382025-03-13Warnings, Adverse reactionsExact identifier
application number: ANDA209838
rxcui: 349556
unii: EOR26LQQ24
EzetimibeEZETIMIBENorthStar Rx LLC5f5644a9-e019-4e5d-ab6f-3d30b1024c5a2025-03-13Warnings, Adverse reactionsExact identifier
application number: ANDA209838
ndc (product): 16714-813
rxcui: 349556
spl id: ce024e9f-19a7-4819-8069-60121c4cf6c4
spl set id: 5f5644a9-e019-4e5d-ab6f-3d30b1024c5a
unii: EOR26LQQ24
EzetimibeEZETIMIBEProficient Rx LP55b18d8f-40e0-48ba-baf1-79a0d1bb2ee22025-03-01Warnings, Adverse reactionsExact identifier
rxcui: 349556
unii: EOR26LQQ24
YVTYVT MICRODERMABRASION FACIAL SCRUBYVTYVT MICRODERMABRASION FACIAL SCRUBBeijing JUNGE Technology Co., Ltd.2f30fc45-42e2-c766-e063-6394a90a8d682025-02-28WarningsExact identifier
unii: OP1R32D61U
EzetimibeEZETIMIBEAmneal Pharmaceuticals NY LLC3fadf4e9-017d-4ccd-91dc-a89b981eb1382025-02-10Warnings, Adverse reactionsExact identifier
rxcui: 349556
unii: EOR26LQQ24
Household AntigensACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, FORMALINUM, GLYPHOSATE, METHYLPARABEN, NAPHTHALINUM, PROPYLPARABEN, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR, PARAFFINUMEnergique, Inc.f3db63df-62a4-48d6-92e7-94e4a57015522024-12-20WarningsExact identifier
unii: 368GB5141J
ezetimibeEZETIMIBEZydus Lifesciences Limitedde814dcd-4759-4e9c-a650-335fb885a79d2024-11-28Exact identifier
rxcui: 349556
unii: EOR26LQQ24
Ezetimibe and SimvastatinEZETIMIBE AND SIMVASTATINAurobindo Pharma Limited79dadfde-35c7-4937-9c82-1728fb6be2fb2024-10-22Warnings, Adverse reactionsExact identifier
unii: EOR26LQQ24
EzetimibeEZETIMIBEA-S Medication Solutions5877150f-2807-435e-8e5b-a07dc7dbfd272024-10-21Warnings, Adverse reactionsExact identifier
rxcui: 349556
unii: EOR26LQQ24
EzetimibeEZETIMIBEA-S Medication Solutions1afdb764-c5da-4982-beae-9be61bdcbcdc2024-10-21Warnings, Adverse reactionsExact identifier
rxcui: 349556
unii: EOR26LQQ24
EzetimibeEZETIMIBEA-S Medication Solutions63ecbbf1-a6de-493f-9710-812ff45cb4d32024-09-29Warnings, Adverse reactionsExact identifier
application number: ANDA209838
rxcui: 349556
unii: EOR26LQQ24
Household AntigensACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUREnergique, Inc.87c92497-8a51-4977-87fe-e0b4c6bafb192024-09-27WarningsExact identifier
unii: 368GB5141J
EzetimibeEZETIMIBEGlenmark Pharmaceuticals Inc., USAac539a72-77e4-419c-b1d9-42002e9cecf72024-07-31Warnings, Adverse reactionsExact identifier
rxcui: 349556
unii: EOR26LQQ24
EZETIMIBEEZETIMIBECamber Pharmaceuticals, Inc.c07fe2e0-dad4-48b5-8a07-7d57a4035ccd2024-07-19Warnings, Adverse reactionsExact identifier
rxcui: 349556
unii: EOR26LQQ24
EzetimibeEZETIMIBEBryant Ranch Prepackd6b4fd12-9954-42ba-b42a-56f3747c47ff2024-07-09Warnings, Adverse reactionsExact identifier
rxcui: 349556
unii: EOR26LQQ24
EzetimibeEZETIMIBEScieGen Pharmaceuticals Inc11de499b-ad8a-46a6-9021-c8eba72ae4142024-06-12Warnings, Adverse reactionsExact identifier
rxcui: 349556
unii: EOR26LQQ24
EzetimibeEZETIMIBEMacleods Pharmaceuticals Limitedebe3fa4e-82c4-4a9a-9aec-f64019391f4e2024-05-13Warnings, Adverse reactionsExact identifier
rxcui: 349556
unii: EOR26LQQ24

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.